Working… Menu

Rifaximin to Modify the Disease Course in Sickle Cell Disease

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03719729
Recruitment Status : Unknown
Verified August 2018 by New York Medical College.
Recruitment status was:  Recruiting
First Posted : October 25, 2018
Last Update Posted : March 14, 2019
Information provided by (Responsible Party):
New York Medical College

No Study Results Posted on for this Study
Recruitment Status : Unknown
Estimated Primary Completion Date : February 22, 2020
Estimated Study Completion Date : July 22, 2020